Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Prev… read more
-
ETF
Equity
- years
45 holdings
$30.52
Price+0.61%
$0.18
$47.189m
Small
$27.924k
Avg Volume$81.704m
$33.05
NAV0.75%
Expense Ratio1.54%
Yield$0.47
Dividend